TEMPE, Ariz.--(BUSINESS WIRE)--Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced that the U.S. Food and Drug ...
Shape Memory Medical Inc. announced that it has reached 50% enrollment in the ongoing AAA-SHAPE Pivotal Trial (NCT06029660) eva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback